Clinical Trials · NCT02075606
Circulating Tumour Cells in Somatuline Autogel Treated NeuroEndocrine Tumours Patients
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Ipsen
- Enrollment
- 50
- Start date
- May 2014
- Locations
- 14 sites, United Kingdom
- Primary endpoint
- Assessment of Clinical Symptomatic Response